Sukhi Thethy
Comptroller/Controller/Auditor bij CHINOOK THERAPEUTICS, INC.
Profiel
Sukhi Thethy is currently the Senior VP-Finance & Accounting at Chinook Therapeutics, Inc. Previously, Thethy worked as the Vice President & Controller at Aimmune Therapeutics, Inc. Thethy is a graduate of San Jose State University.
Actieve functies van Sukhi Thethy
Bedrijven | Functie | Begin |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Eerdere bekende functies van Sukhi Thethy
Bedrijven | Functie | Einde |
---|---|---|
AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Opleiding van Sukhi Thethy
San Jose State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |